Latest Integral Health Asset Management, LLC Stock Portfolio
$2.09Billion– No. of Holdings #86
Integral Health Asset Management, LLC Performance:
2026 Q1: -1.82%YTD: -1.82%2025: 38.01%
Performance for 2026 Q1 is -1.82%, and YTD is -1.82%, and 2025 is 38.01%.
About Integral Health Asset Management, LLC and 13F Hedge Fund Stock Holdings
Integral Health Asset Management, LLC is a hedge fund based in New York, NY. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Integral Health Asset Management, LLC reported an equity portfolio of $2.1 Billions as of 31 Mar, 2026.
The top stock holdings of Integral Health Asset Management, LLC are INSM, RVMD, CYTK. The fund has invested 11.7% of it's portfolio in INSMED INC and 7% of portfolio in REVOLUTION MEDICINES INC.
The fund managers got completely rid off MEDTRONIC PLC (MDT), ASTRAZENECA PLC (AZN) and TEVA PHARMACEUTICAL INDS LTD (TEVA) stocks. They significantly reduced their stock positions in CVS HEALTH CORP (CVS), INTUITIVE SURGICAL INC (ISRG) and DEXCOM INC (DXCM). Integral Health Asset Management, LLC opened new stock positions in ASTRAZENECA PLC, BRIDGEBIO PHARMA INC (BBIO) and VERTEX PHARMACEUTICALS INC (VRTX). The fund showed a lot of confidence in some stocks as they added substantially to ARROWHEAD PHARMACEUTICALS IN (ARWR), VIKING THERAPEUTICS INC (VKTX) and BOSTON SCIENTIFIC CORP (BSX).
The top stock holdings of Integral Health Asset Management, LLC are INSM, RVMD, CYTK. The fund has invested 11.7% of it's portfolio in INSMED INC and 7% of portfolio in REVOLUTION MEDICINES INC.
The fund managers got completely rid off MEDTRONIC PLC (MDT), ASTRAZENECA PLC (AZN) and TEVA PHARMACEUTICAL INDS LTD (TEVA) stocks. They significantly reduced their stock positions in CVS HEALTH CORP (CVS), INTUITIVE SURGICAL INC (ISRG) and DEXCOM INC (DXCM). Integral Health Asset Management, LLC opened new stock positions in ASTRAZENECA PLC, BRIDGEBIO PHARMA INC (BBIO) and VERTEX PHARMACEUTICALS INC (VRTX). The fund showed a lot of confidence in some stocks as they added substantially to ARROWHEAD PHARMACEUTICALS IN (ARWR), VIKING THERAPEUTICS INC (VKTX) and BOSTON SCIENTIFIC CORP (BSX).
Integral Health Asset Management, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
Integral Health Asset Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Integral Health Asset Management, LLC made a return of -1.82% in the last quarter. In trailing 12 months, it's portfolio return was 40.5%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| astrazeneca plc | 49,305,000 |
| bridgebio pharma inc | 20,421,500 |
| vertex pharmaceuticals inc | 17,861,600 |
| alumis inc | 17,624,000 |
| gilead sciences inc | 13,937,000 |
| cogent biosciences inc | 13,471,500 |
| madrigal pharmaceuticals inc | 13,086,800 |
| xenon pharmaceuticals inc | 11,630,000 |
New stocks bought by Integral Health Asset Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| arrowhead pharmaceuticals in | 200 |
| viking therapeutics inc | 150 |
| boston scientific corp | 144 |
| roivant sciences ltd | 135 |
| nurix therapeutics inc | 133 |
| tango therapeutics inc | 125 |
| elanco animal health inc | 120 |
| evommune inc | 80.00 |
Additions to existing portfolio by Integral Health Asset Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| cvs health corp | -70.00 |
| intuitive surgical inc | -68.18 |
| dexcom inc | -65.00 |
| cooper cos inc | -53.85 |
| edwards lifesciences corp | -47.69 |
| glaukos corp | -46.15 |
| beam therapeutics inc | -45.45 |
| dianthus therapeutics inc | -45.45 |
Integral Health Asset Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| gossamer bio inc | -3,100,000 |
| teva pharmaceutical inds ltd | -31,210,000 |
| upstream bio inc | -20,362,500 |
| medtronic plc | -64,840,500 |
| sight sciences inc | -3,370,250 |
| terns pharmaceuticals inc | -17,170,000 |
| doximity inc | -17,712,000 |
| astrazeneca plc | -32,175,500 |
Integral Health Asset Management, LLC got rid off the above stocks
Sector Distribution
Integral Health Asset Management, LLC has about 84.5% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 84.5 |
| Others | 15.5 |
Market Cap. Distribution
Integral Health Asset Management, LLC has about 47.7% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- MID-CAP
- UNALLOCATED
- SMALL-CAP
- MEGA-CAP
- NANO-CAP
| Category | % |
|---|---|
| LARGE-CAP | 44.3 |
| MID-CAP | 28.8 |
| UNALLOCATED | 15.5 |
| SMALL-CAP | 5.8 |
| MEGA-CAP | 3.4 |
| NANO-CAP | 1.2 |
Stocks belong to which Index?
About 73% of the stocks held by Integral Health Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
- S&P 500
| Index | % |
|---|---|
| RUSSELL 2000 | 52.9 |
| Others | 27 |
| S&P 500 | 20.1 |
Integral Health Asset Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Integral Health Asset Management, LLC
Integral Health Asset Management, LLC has 86 stocks in it's portfolio. About 42.8% of the portfolio is in top 10 stocks. VERA proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for Integral Health Asset Management, LLC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACHC | acadia healthcare company in | 0.22 | 200,000 | 4,678,000 | new | |||
| ACLX | arcellx inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALHC | alignment healthcare inc | 2.17 | 2,575,000 | 45,371,500 | added | 17.05 | ||
| ALNY | alnylam pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANTX | elevance health inc formerly | 1.05 | 75,000 | 21,956,200 | added | 25.00 | ||
| APLS | apellis pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARWR | arrowhead pharmaceuticals in | 0.90 | 300,000 | 18,810,000 | added | 200 | ||
| ASND | ascendis pharma a/s | 1.26 | 115,000 | 26,304,000 | added | 27.78 | ||
| AXSM | axsome therapeutics inc. | 0.28 | 35,000 | 5,915,700 | new | |||
| AZN | astrazeneca plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma inc | 0.98 | 275,000 | 20,421,500 | new | |||
| BCRX | biocryst pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BEAM | beam therapeutics inc | 0.34 | 300,000 | 7,149,000 | reduced | -45.45 | ||
| BIIB | biogen inc | 0.53 | 60,000 | 10,999,800 | reduced | -40.00 | ||
| BRKR | bruker corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BSX | boston scientific corp | 1.65 | 550,000 | 34,512,500 | added | 144 | ||
| CAH | cardinal health inc | 2.73 | 270,000 | 57,053,700 | added | 35.00 | ||
| CAPR | capricor therapeutics inc | 0.29 | 200,000 | 6,080,000 | new | |||
| CELC | celcuity inc | 0.44 | 80,000 | 9,131,200 | unchanged | 0.00 | ||
| CNC | centene corp del | 1.02 | 650,000 | 21,281,000 | unchanged | 0.00 | ||